Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Thompson

Showing results (191-200 of 227) with videos related to

Pageof 23
Sort By:
British Journal of Cancer|July 29, 2010
Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based studyC A Purdie, L Baker, A Ashfield, et al.
British Journal of Cancer|July 1, 1990
Gene expression in oestrogen-dependent human breast cancer xenograft tumoursA M Thompson, C M Steel, M E Foster, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 31, 2012
Involved anterior margins after breast conserving surgery: is re-excision required?R Mullen, E J Macaskill, A Khalil, et al.
Oncogene|November 3, 2010
Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcomeL A Henry, D A Johnson, D Sarrió, et al.
Journal of Medicinal Chemistry|April 26, 1996
Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptorG W Rewcastle, B D Palmer, A M Thompson, et al.
Journal of Medicinal Chemistry|January 6, 1995
Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinasesB D Palmer, G W Rewcastle, A M Thompson, et al.
New Zealand Veterinary Journal|June 1, 1997
A zinc-containing intraruminal device for facial eczema control in lambsR Munday, A M Thompson, E A Fowke, et al.
Journal of Medicinal Chemistry|December 16, 1997
Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorA M Thompson, D K Murray, W L Elliott, et al.
Oncogene|September 7, 2010
The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancerH C Moore, L B Jordan, S E Bray, et al.
British Journal of Cancer|February 25, 2012
Phenformin as prophylaxis and therapy in breast cancer xenograftsM V C L Appleyard, K E Murray, P J Coates, et al.
Pageof 23

Showing results (191-200 of 227) with videos related to

Sort By:
Pageof 23
British Journal of Cancer|July 29, 2010
Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based studyC A Purdie, L Baker, A Ashfield, et al.
British Journal of Cancer|July 1, 1990
Gene expression in oestrogen-dependent human breast cancer xenograft tumoursA M Thompson, C M Steel, M E Foster, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 31, 2012
Involved anterior margins after breast conserving surgery: is re-excision required?R Mullen, E J Macaskill, A Khalil, et al.
Oncogene|November 3, 2010
Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcomeL A Henry, D A Johnson, D Sarrió, et al.
Journal of Medicinal Chemistry|April 26, 1996
Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptorG W Rewcastle, B D Palmer, A M Thompson, et al.
Journal of Medicinal Chemistry|January 6, 1995
Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinasesB D Palmer, G W Rewcastle, A M Thompson, et al.
New Zealand Veterinary Journal|June 1, 1997
A zinc-containing intraruminal device for facial eczema control in lambsR Munday, A M Thompson, E A Fowke, et al.
Journal of Medicinal Chemistry|December 16, 1997
Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorA M Thompson, D K Murray, W L Elliott, et al.
Oncogene|September 7, 2010
The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancerH C Moore, L B Jordan, S E Bray, et al.
British Journal of Cancer|February 25, 2012
Phenformin as prophylaxis and therapy in breast cancer xenograftsM V C L Appleyard, K E Murray, P J Coates, et al.
Pageof 23